Shoron Mowla

3PUBLICATIONS
49CO-AUTHORS
Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 17, 2024
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.

Andrew J Dunbar, Robert L Bowman, Young C Park

|Mar 30, 2021
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms.

Raajit K Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara

Pageof 1